Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure - Wikidata - awgldk - TriplyDB

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

http://www.wikidata.org/entity/Q28300297

about

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure State of the Art: Newer biomarkers in heart failure Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.Emerging biomarkers in heart failure and cardiac cachexia Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy.Soluble ST2 protein in chronic heart failure is independent of traditional factors.Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: a paradoxic role for inflammatory mediators?The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.Soluble ST2 predicts elevated SBP in the community ST2: a novel biomarker for heart failure.Genetics of interleukin 1 receptor-like 1 in immune and inflammatory diseases.Role of IL-33 in inflammation and disease.Novel biomarkers in chronic heart failure.The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.ST2 as a cardiovascular risk biomarker: from the bench to the bedside.Heart failure biomarkers.Clinical use of novel biomarkers in heart failure: towards personalized medicine.The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers.A novel cardiac bio-marker: ST2: a review.BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.Using ST2 in cardiovascular patients: a review.Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot?Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.Using biomarkers to guide heart failure management.ST2 and Galectin-3: Ready for Prime Time?Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2.Temporal changes of soluble ST2 after cardiovascular interventions.Soluble ST2: A Novel Prognostic Biomarker of Heart Failure.ST2 Predicts Mortality and Length of Stay in a Critically Ill Noncardiac Intensive Care Unit Population.The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality.Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.Role of point of care - ST2, Galectin-3 and adrenomedullin in the evaluation and treatment of emergency patients.

P2860

Q24610732-D12811C5-E5BA-4A38-B5BA-AAAA797EB3CE Q27027899-40EA051E-4457-47FA-B3AB-77EAC9BAA09F Q28066438-13A61186-B078-45E9-8863-958DAE7FF92B Q30458086-B308B67F-8C58-453A-8D54-672C6681DF2C Q34408467-F63328C3-26D1-4E9B-B09E-543D13AC7D2F Q34836097-9E4945B2-C774-4F01-BD01-92B13A018158 Q35553684-941783D1-5236-41D7-B008-09871929581A Q36569151-51007E69-C1FC-481F-8E22-68CF7052E6D2 Q36633934-44864F8B-F567-42F5-AB9C-E9975AF9D63E Q36686088-C5F29233-4BF4-4B7F-BA65-EF653B5071CF Q36851584-EB3ED3BC-10AF-4A45-AF2B-28492687EB44 Q37200836-6144CD91-8985-456F-963D-F3BF7C281272 Q37240346-1416FCDE-D764-4C90-814B-07C9EA25B970 Q37413342-EB94D833-040B-40B1-BBE4-4197CDB4A7C1 Q37602424-049FDDC3-D015-412D-B10F-C1D501BEEEEF Q37702150-F022D1DF-2EE6-4391-A49A-A92FC09A07E0 Q37750852-BC7CC81E-1369-4AC9-A740-5D65F2AE9C74 Q37883044-B46C1F59-B983-4CA3-965A-7A9E1B92E6B1 Q37922810-EB02B557-BB03-4401-829C-B5EC5E94873D Q37997237-D1530E99-F189-45CA-AB98-8B33B6750E89 Q38068933-8DA051D6-D54A-4EBB-83A0-863D35C287A7 Q38096251-6FD90C45-CAE9-4E03-BE1D-DD1778659732 Q38100647-B18E53C2-2EEC-4944-8EBE-B94FABF0DE39 Q38109588-5B0E0A6F-F7D0-4A03-AD40-1CA7009F414C Q38154222-006147F9-9120-4546-B025-C425757DE089 Q38171069-32522833-9BC8-46B6-AC39-378EB03BC817 Q38233991-FAF6A9D2-A8D5-4D53-A8B9-0804DC5F6457 Q38258665-489E0E86-DCFC-4F7D-8ED1-8F575F8FB751 Q38287064-DDC4DCCB-CE43-4CDB-9294-6C72F1BA59FE Q38380593-39B313D2-C92C-4B0D-894E-3688EB1C4565 Q38551693-7EB54DA6-FAC5-4C84-885B-48C51A0CBE91 Q38613842-F0A1DB2C-850F-41FC-A9D3-C5297A0D8503 Q38816590-FD9E8834-2B80-4DF1-8B9F-653A06E66B4D Q38967451-21BF0675-87BA-4074-B41E-BB54DCF11D29 Q39507885-422A57E8-1156-4841-BB10-6B7C84217BEA Q40288404-741338CC-9130-404F-895B-2CC694EAEDF2 Q40921882-1192C22D-11F2-40FB-86E9-7A0CDDFB9A1A Q40976941-FAFDF25A-060E-43B6-8C28-5C0CF21FBFC6 Q41007543-CBC80613-DD71-4DE7-8F29-4C82EEA1B3AB Q42948538-6141BADA-C2A5-4E9C-B248-0B29969311B4

P2860

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

http://www.wikidata.org/entity/Q28300297

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@ast

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@en

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@nl

type

label

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@ast

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@en

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@nl

prefLabel

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@ast

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@en

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@nl

P1433

Q28300297-8D637321-18EC-43F0-AF4F-D43E602336DF

P1476

Q28300297-EE94958F-6970-4CCC-B28D-A87189DCA4B9

P2093

Q28300297-29C73EF8-0D18-4406-9845-46282E6BAC8A

Q28300297-36E13C8F-804A-46D8-9790-4DC8515DF4C7

Q28300297-4AFA3195-C29A-481D-8BA1-BA9C517B02B9

Q28300297-ADEA90D1-7B34-4259-81DE-D0DD19331C14

Q28300297-CEBF7494-0AD6-479A-9535-BF4C4AF3BB75

Q28300297-D8A7839D-7150-48A2-9E15-25322FBE9AF2

Q28300297-DB1F1B60-6F5B-47B2-A3E3-9CD291A4B083

P304

Q28300297-268D74F1-13CA-48C2-8A54-0F7512D1CD28

P31

Q28300297-54EF0186-BD40-423A-8B98-BC19D7C5E5CA

P3181

Q28300297-6B64C6BE-F091-4267-8E1C-05E73C339CED

P356

Q28300297-662F2B2D-A7A3-40E0-ABE0-8F206385409A

P407

Q28300297-FF0D0543-F7C1-4814-A7A4-A7CBFE69B8BF

P433

Q28300297-03905750-4EB4-4268-9E37-F43E311B4768

P478

Q28300297-0C776C37-5398-48A9-9F09-F18B858B959B

P50

Q28300297-04E2799E-B010-44B6-9BD8-FEB8731D6386

P577

Q28300297-BFF054E3-28D5-4F08-A215-8A7D89F3A2BB

P698

Q28300297-305AF490-1C38-4D92-AB6F-9836BF074B32

P921

Q28300297-4A7BE7C5-43F8-4FD6-B8F6-0F2023372B2B

P3181

P356

J.CARDFAIL.2008.06.415

P1433

Journal of Cardiac Failure

P1476

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

@en

P2093

Alan S Maisel

http://www.w3.org/2001/XMLSchema#string

Albert Chiu

http://www.w3.org/2001/XMLSchema#string

Jennifer Beede

http://www.w3.org/2001/XMLSchema#string

Paul Clopton

http://www.w3.org/2001/XMLSchema#string

Robert L Fitzgerald

http://www.w3.org/2001/XMLSchema#string

Saskia Boisot

http://www.w3.org/2001/XMLSchema#string

Susan Isakson

http://www.w3.org/2001/XMLSchema#string

P304

732-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4204983

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CARDFAIL.2008.06.415

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

James L Januzzi

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18995177

http://www.w3.org/2001/XMLSchema#string

P921